vs
Side-by-side financial comparison of Brightstar Lottery PLC (BRSL) and Dexcom (DXCM). Click either name above to swap in a different company.
Brightstar Lottery PLC is the larger business by last-quarter revenue ($2.5B vs $1.3B, roughly 2.0× Dexcom). Dexcom runs the higher net margin — 21.2% vs 5.9%, a 15.4% gap on every dollar of revenue.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
BRSL vs DXCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $1.3B |
| Net Profit | $147.0M | $267.3M |
| Gross Margin | — | 62.9% |
| Operating Margin | 11.9% | 25.6% |
| Net Margin | 5.9% | 21.2% |
| Revenue YoY | — | 21.6% |
| Net Profit YoY | — | 153.6% |
| EPS (diluted) | $0.74 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $2.5B | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $994.2M | ||
| Q2 24 | — | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | $147.0M | $267.3M | ||
| Q3 25 | — | $283.8M | ||
| Q2 25 | — | $179.8M | ||
| Q1 25 | — | $105.4M | ||
| Q4 24 | — | $151.7M | ||
| Q3 24 | — | $134.6M | ||
| Q2 24 | — | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | — | 62.9% | ||
| Q3 25 | — | 60.5% | ||
| Q2 25 | — | 59.5% | ||
| Q1 25 | — | 56.9% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | 11.9% | 25.6% | ||
| Q3 25 | — | 20.1% | ||
| Q2 25 | — | 18.4% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | 5.9% | 21.2% | ||
| Q3 25 | — | 23.5% | ||
| Q2 25 | — | 15.5% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.5% | ||
| Q2 24 | — | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | $0.74 | $0.67 | ||
| Q3 25 | — | $0.70 | ||
| Q2 25 | — | $0.45 | ||
| Q1 25 | — | $0.27 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.34 | ||
| Q2 24 | — | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $917.7M |
| Total DebtLower is stronger | $4.1B | — |
| Stockholders' EquityBook value | $875.0M | $2.7B |
| Total Assets | $9.2B | $6.3B |
| Debt / EquityLower = less leverage | 4.64× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | $1.4B | $917.7M | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $904.9M | ||
| Q4 24 | — | $606.1M | ||
| Q3 24 | — | $621.2M | ||
| Q2 24 | — | $939.2M |
| Q1 26 | — | — | ||
| Q4 25 | $4.1B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $875.0M | $2.7B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $9.2B | $6.3B | ||
| Q3 25 | — | $7.5B | ||
| Q2 25 | — | $7.3B | ||
| Q1 25 | — | $6.8B | ||
| Q4 24 | — | $6.5B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.8B |
| Q1 26 | — | — | ||
| Q4 25 | 4.64× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-99.0M | — |
| Free Cash FlowOCF − Capex | $-415.0M | — |
| FCF MarginFCF / Revenue | -16.5% | — |
| Capex IntensityCapex / Revenue | 12.6% | — |
| Cash ConversionOCF / Net Profit | -0.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-99.0M | $294.0M | ||
| Q3 25 | — | $659.9M | ||
| Q2 25 | — | $303.0M | ||
| Q1 25 | — | $183.8M | ||
| Q4 24 | — | $301.4M | ||
| Q3 24 | — | $199.5M | ||
| Q2 24 | — | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-415.0M | $192.1M | ||
| Q3 25 | — | $579.4M | ||
| Q2 25 | — | $208.9M | ||
| Q1 25 | — | $96.8M | ||
| Q4 24 | — | $176.8M | ||
| Q3 24 | — | $88.3M | ||
| Q2 24 | — | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | -16.5% | 15.3% | ||
| Q3 25 | — | 47.9% | ||
| Q2 25 | — | 18.1% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 12.6% | 8.1% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 8.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | -0.67× | 1.10× | ||
| Q3 25 | — | 2.33× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
